# NFKB1

## Overview
The NFKB1 gene encodes the nuclear factor kappa B subunit 1 (NF-κB1), a critical component of the NF-κB transcription factor complex, which plays a pivotal role in regulating immune responses, inflammation, and cell survival. The gene product, p105, is a precursor protein that undergoes proteasomal processing to form the p50 subunit, a key player in NF-κB signaling pathways. As a transcription factor, NF-κB1 is involved in the regulation of genes responsive to various stimuli, including cytokines and stress signals, thereby influencing processes such as immune cell maturation and antibody production (Lougaris2017NFKB1; Cartwright2016NFKB1:). Mutations in NFKB1 are associated with immunodeficiencies, such as common variable immunodeficiency (CVID), and can lead to a spectrum of clinical manifestations, including recurrent infections and autoimmune disorders (Tuijnenburg2018Lossoffunction; Fliegauf2015Haploinsufficiency). The protein's ability to form homo- and heterodimers with other NF-κB subunits underscores its importance in maintaining immune homeostasis and cellular responses to environmental changes (Savinova2009The).

## Structure
The NFKB1 gene encodes the precursor protein p105, which is processed into the p50 subunit of the NF-κB transcription factor. The p105 protein is a multidomain structure consisting of several key regions: the N-terminal domain (NTD), a dimerization domain (DimD), an ankyrin repeat domain (ARD), and a death domain (DD) (Moorthy2006The). The N-terminal Rel homology domain (RHD) is crucial for DNA binding, dimerization, and interaction with inhibitor of NF-kB (IkB) proteins (Fliegauf2022Detrimental). The RHD also includes a nuclear localization signal and a glycine-rich region that acts as a proteasome stop signal during the processing of p105 to p50 (Cartwright2016NFKB1:).

The C-terminal region of p105, known as IkBg, functions as an inhibitor of NF-kB transcriptional activity (Moorthy2006The). The p105 protein undergoes limited proteasomal processing by the 20S proteasome, which selectively degrades the C-terminus to generate p50 in a ubiquitin-independent manner (Moorthy2006The). Post-translational modifications, such as phosphorylation and ubiquitination, affect the stability and DNA-binding ability of p105/p50 (Cartwright2016NFKB1:).

In terms of quaternary structure, p105 can form high-molecular-weight complexes through dimerization of its RHD and interactions with ankyrin repeats, which are crucial for the assembly and regulation of NF-kB signaling (Savinova2009The). The p50 subunit, derived from p105, can form homo- and heterodimers, often pairing with RelA to regulate gene transcription (Cartwright2016NFKB1:).

## Function
The NFKB1 gene encodes a subunit of the NF-κB transcription factor, which is crucial for regulating immune responses, inflammation, and cell survival in healthy human cells. NF-κB is involved in the transcriptional regulation of various genes in response to stimuli such as lipopolysaccharide (LPS), tumor necrosis factor α (TNFα), and interleukin 1β (IL-1β) (Schipp2016Specific). The gene product, p50, forms part of the NF-κB complex that translocates to the nucleus to activate target gene expression (Schipp2016Specific). 

In the context of immune function, NFKB1 is essential for the maturation and effector functions of natural killer (NK) cells, including the regulation of markers and receptors critical for NK cell maturation and their ability to produce interferon-gamma (IFN-γ), a key cytokine in immune responses (Lougaris2017NFKB1). The canonical NF-κB pathway, involving NFKB1, is necessary for the proper activation and function of NK cells (Lougaris2017NFKB1). 

NFKB1 also plays a role in the regulation of immunoglobulin class-switching, which is essential for producing different types of antibodies, highlighting its importance in adaptive immunity (Tuijnenburg2018Lossoffunction).

## Clinical Significance
Mutations in the NFKB1 gene are a significant cause of common variable immunodeficiency (CVID), particularly in European populations. These mutations often result in a loss of function of the NF-kB1 p50 subunit, leading to reduced protein levels and impaired immune responses (Tuijnenburg2018Lossoffunction; Fliegauf2015Haploinsufficiency). The clinical manifestations of NFKB1 mutations are diverse, including hypogammaglobulinemia, recurrent infections, autoimmune phenomena, and chronic lung disease (Schipp2016Specific). 

Heterozygous loss-of-function mutations in NFKB1 can lead to haploinsufficiency, where the reduced expression of the p50 subunit affects immune homeostasis and contributes to CVID (Fliegauf2015Haploinsufficiency). These mutations are associated with a range of phenotypes, from antibody deficiency to multiorgan autoinflammatory conditions (Lorenzini2020Characterization). 

The mutations can also result in defective isotype switching and somatic hypermutation, increasing the presence of autoreactive B cells and leading to autoimmune complications (Lorenzini2020Characterization). The clinical significance of NFKB1 mutations extends to oncological manifestations, with cases of both solid tumors and hematologic malignancies reported (Tuijnenburg2018Lossoffunction).

## Interactions
The NFKB1 gene encodes the precursor protein p105, which is processed into the mature NF-kB transcription factor subunit p50. This protein is involved in various interactions crucial for NF-kB signaling. p105 and its processed form, p50, participate in forming high-molecular-weight complexes through interactions with other NF-kB subunits and inhibitors. These interactions occur via the Rel Homology Domain (RHD) and Ankyrin (ANK) domains, allowing p105 and p50 to bind with other NF-kB polypeptides and preformed NF-kB dimers (Savinova2009The).

p105 can interact with RelA, c-Rel, and other NF-kB subunits, forming part of high-molecular-weight complexes that regulate NF-kB dimer formation and function as inhibitors of latent NF-kB dimers (Savinova2009The). The p50 subunit, derived from p105, can form heterodimers with other NF-kB family members, such as p65 (RelA), which is the most abundant form found in almost all cell types (Oeckinghaus2009The).

The p105 protein also interacts with inhibitory proteins like IkB, which sequester NF-kB dimers in the cytoplasm. Upon phosphorylation by the IkB kinase (IKK) complex, these dimers translocate to the nucleus to induce transcription of target genes (Oeckinghaus2009The). The Tyr350Cys mutation in NFKB1 affects the protein's ability to interact effectively with RelA, impacting transcriptional regulation mediated by NF-kB (Fliegauf2021A).


## References


[1. (Schipp2016Specific) C. Schipp, S. Nabhani, K. Bienemann, N. Simanovsky, S. Kfir-Erenfeld, N. Assayag-Asherie, P. T. Oommen, S. Revel-Vilk, A. Honscheid, M. Gombert, S. Ginzel, D. Schafer, H.-J. Laws, E. Yefenof, B. Fleckenstein, A. Borkhardt, P. Stepensky, and U. Fischer. Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous nfkb1 loss-of-function mutations in humans. Haematologica, 101(10):e392–e396, June 2016. URL: http://dx.doi.org/10.3324/haematol.2016.145136, doi:10.3324/haematol.2016.145136. This article has 39 citations.](https://doi.org/10.3324/haematol.2016.145136)

[2. (Savinova2009The) Olga V. Savinova, Alexander Hoffmann, and Gourisankar Ghosh. The nfkb1 and nfkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes. Molecular Cell, 34(5):591–602, June 2009. URL: http://dx.doi.org/10.1016/j.molcel.2009.04.033, doi:10.1016/j.molcel.2009.04.033. This article has 119 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2009.04.033)

[3. (Oeckinghaus2009The) A. Oeckinghaus and S. Ghosh. The nf- b family of transcription factors and its regulation. Cold Spring Harbor Perspectives in Biology, 1(4):a000034–a000034, September 2009. URL: http://dx.doi.org/10.1101/cshperspect.a000034, doi:10.1101/cshperspect.a000034. This article has 1996 citations and is from a peer-reviewed journal.](https://doi.org/10.1101/cshperspect.a000034)

[4. (Lorenzini2020Characterization) Tiziana Lorenzini, Manfred Fliegauf, Nils Klammer, Natalie Frede, Michele Proietti, Alla Bulashevska, Nadezhda Camacho-Ordonez, Markku Varjosalo, Matias Kinnunen, Esther de Vries, Jos W.M. van der Meer, Rohan Ameratunga, Chaim M. Roifman, Yael D. Schejter, Robin Kobbe, Timo Hautala, Faranaz Atschekzei, Reinhold E. Schmidt, Claudia Schröder, Polina Stepensky, Bella Shadur, Luis A. Pedroza, Michiel van der Flier, Mónica Martínez-Gallo, Luis Ignacio Gonzalez-Granado, Luis M. Allende, Anna Shcherbina, Natalia Kuzmenko, Victoria Zakharova, João Farela Neves, Peter Svec, Ute Fischer, Winnie Ip, Oliver Bartsch, Safa Barış, Christoph Klein, Raif Geha, Janet Chou, Mohammed Alosaimi, Lauren Weintraub, Kaan Boztug, Tatjana Hirschmugl, Maria Marluce Dos Santos Vilela, Dirk Holzinger, Maximilian Seidl, Vassilios Lougaris, Alessandro Plebani, Laia Alsina, Monica Piquer-Gibert, Angela Deyà-Martínez, Charlotte A. Slade, Asghar Aghamohammadi, Hassan Abolhassani, Lennart Hammarström, Outi Kuismin, Merja Helminen, Hana Lango Allen, James E. Thaventhiran, Alexandra F. Freeman, Matthew Cook, Shahrzad Bakhtiar, Mette Christiansen, Charlotte Cunningham-Rundles, Niraj C. Patel, William Rae, Tim Niehues, Nina Brauer, Jaana Syrjänen, Mikko R.J. Seppänen, Siobhan O. Burns, Paul Tuijnenburg, Taco W. Kuijpers, Klaus Warnatz, Bodo Grimbacher, Zoe Adhya, Hana Alachkar, Ariharan Anantharachagan, Richard Antrobus, Gururaj Arumugakani, Sofie Ashford, William J. Astle, Anthony Attwood, Chiara Bacchelli, Joana Batista, Helen E. Baxendale, Claire Bethune, Shahnaz Bibi, Marta Bleda, Barbara Boardman, Claire Booth, John R. Bradley, Gerome Breen, Matthew Brown, Michael J. Browning, Mary Brownlie, Matthew S. Buckland, Siobhan O. Burns, Oliver S. Burren, Keren Carss, John Chambers, Anita Chandra, Naomi Clements Brod, Hayley Clifford, Nichola Cooper, Louise C. Daugherty, E.G. Davies, Sophie Davies, John Davis, Sarah Deacock, Sri V.V. Deevi, John Dempster, Lisa A. Devlin, Eleanor F. Dewhurst, Kate Downes, Elizabeth Drewe, Daniel Duarte, J. David M. Edgar, Karen Edwards, William Egner, Tariq El-Shanawany, Marie Erwood, Debra Fletcher, James Fox, Amy J. Frary, Mattia Frontini, Abigail Furnell, H. Bobby Gaspar, Rohit Ghurye, Kimberly C. Gilmour, Nicholas S. Gleadall, Sarah Goddard, Pavels Gordins, Stefan Gräf, Luigi Grassi, Daniel Greene, Sofia Grigoriadou, Scott Hackett, Rosie Hague, Matthias Haimel, Lorraine Harper, Grant Hayman, Archana Herwadkar, Fengyuan Hu, Stephen Hughes, Aarnoud P. Huissoon, Roger James, Stephen Jolles, Jennifer Jolley, Julie Jones, Yousuf Karim, Mary A. Kasanicki, Peter Kelleher, Carly Kempster, Sorena Kiani, Nathalie Kingston, Nigel Klein, Myrto Kostadima, Roman Kreuzhuber, Taco W. Kuijpers, Dinakantha Kumararatne, James Laffan, Hana Lango Allen, Sara E. Lear, Rachel Linger, Hilary Longhurst, Lorena E. Lorenzo, Paul A. Lyons, Jesmeen Maimaris, Ania Manson, Rutendo Mapeta, Jennifer Martin, Mark I. McCarthy, Elizabeth M. McDermott, Harriet McKinney, Stuart Meacham, Karyn Megy, Hazel Millar, Anoop Mistry, Valerie Morrisson, Sai H.K. Murng, Iman Nasir, Sergey Nejentsev, Sadia Noorani, Eric Oksenhendler, Willem H. Ouwehand, Sofia Papadia, Christopher J. Penkett, Romina Petersen, Mark J. Ponsford, Waseem Qasim, Ellen Quinn, Isabella Quinti, F. Lucy Raymond, Paula J. Rayner-Matthews, Alex Richter, Nilesh Samani, Crina Samarghitean, Alba Sanchis-Juan, Ravishankar B. Sargur, Sinisa Savic, Suranjith L. Seneviratne, W.A. Carrock Sewell, Denis Seyres, Fiona Shackley, Olga Shamardina, Ilenia Simeoni, Michael A. Simpson, Kenneth G.C. Smith, Simon Staines, Emily Staples, Hannah Stark, Hans Stauss, Cathal L. Steele, Jonathan Stephens, Kathleen E. Stirrups, James E. Thaventhiran, David Thomas, Moira J. Thomas, Patrick Thomas, Adrian J. Thrasher, Tobias Tilly, Catherine Titterton, Paul Treadaway, Salih Tuna, Ernest Turro, Rafal Urniaz, Julie von Ziegenweidt, Neil Walker, Christopher Watt, Steven B. Welch, Deborah Whitehorn, Lisa Willcocks, Nicholas Wood, Yvette Wood, Sarita Workman, Austen Worth, Katherine Yates, Nigel Yeatman, Patrick F.K. Yong, Timothy Young, Ping Yu, and Eliska Zlamalova. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous nfkb1 mutations. Journal of Allergy and Clinical Immunology, 146(4):901–911, October 2020. URL: http://dx.doi.org/10.1016/j.jaci.2019.11.051, doi:10.1016/j.jaci.2019.11.051. This article has 81 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2019.11.051)

[5. (Lougaris2017NFKB1) Vassilios Lougaris, Ornella Patrizi, Manuela Baronio, Giovanna Tabellini, Giacomo Tampella, Eufemia Damiati, Natalie Frede, Jos W.M. van der Meer, Manfred Fliegauf, Bodo Grimbacher, Silvia Parolini, and Alessandro Plebani. Nfkb1 regulates human nk cell maturation and effector functions. Clinical Immunology, 175:99–108, February 2017. URL: http://dx.doi.org/10.1016/j.clim.2016.11.012, doi:10.1016/j.clim.2016.11.012. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.clim.2016.11.012)

[6. (Cartwright2016NFKB1:) Tyrell Cartwright, Neil D. Perkins, and Caroline L. Wilson. Nfkb1: a suppressor of inflammation, ageing and cancer. The FEBS Journal, 283(10):1812–1822, January 2016. URL: http://dx.doi.org/10.1111/febs.13627, doi:10.1111/febs.13627. This article has 225 citations.](https://doi.org/10.1111/febs.13627)

[7. (Tuijnenburg2018Lossoffunction) Paul Tuijnenburg, Hana Lango Allen, Siobhan O. Burns, Daniel Greene, Machiel H. Jansen, Emily Staples, Jonathan Stephens, Keren J. Carss, Daniele Biasci, Helen Baxendale, Moira Thomas, Anita Chandra, Sorena Kiani-Alikhan, Hilary J. Longhurst, Suranjith L. Seneviratne, Eric Oksenhendler, Ilenia Simeoni, Godelieve J. de Bree, Anton T.J. Tool, Ester M.M. van Leeuwen, Eduard H.T.M. Ebberink, Alexander B. Meijer, Salih Tuna, Deborah Whitehorn, Matthew Brown, Ernest Turro, Adrian J. Thrasher, Kenneth G.C. Smith, James E. Thaventhiran, Taco W. Kuijpers, Zoe Adhya, Hana Alachkar, Ariharan Anantharachagan, Richard Antrobus, Gururaj Arumugakani, Chiara Bacchelli, Helen Baxendale, Claire Bethune, Shahnaz Bibi, Barbara Boardman, Claire Booth, Michael Browning, Mary Brownlie, Siobhan Burns, Anita Chandra, Hayley Clifford, Nichola Cooper, Sophie Davies, John Dempster, Lisa Devlin, Rainer Doffinger, Elizabeth Drewe, David Edgar, William Egner, Tariq El-Shanawany, Bobby Gaspar, Rohit Ghurye, Kimberley Gilmour, Sarah Goddard, Pavel Gordins, Sofia Grigoriadou, Scott Hackett, Rosie Hague, Lorraine Harper, Grant Hayman, Archana Herwadkar, Stephen Hughes, Aarnoud Huissoon, Stephen Jolles, Julie Jones, Peter Kelleher, Nigel Klein, Taco Kuijpers, Dinakantha Kumararatne, James Laffan, Hana Lango Allen, Sara Lear, Hilary Longhurst, Lorena Lorenzo, Jesmeen Maimaris, Ania Manson, Elizabeth McDermott, Hazel Millar, Anoop Mistry, Valerie Morrisson, Sai Murng, Iman Nasir, Sergey Nejentsev, Sadia Noorani, Eric Oksenhendler, Mark Ponsford, Waseem Qasim, Ellen Quinn, Isabella Quinti, Alex Richter, Crina Samarghitean, Ravishankar Sargur, Sinisa Savic, Suranjith Seneviratne, Carrock Sewall, Fiona Shackley, Ilenia Simeoni, Kenneth G.C. Smith, Emily Staples, Hans Stauss, Cathal Steele, James Thaventhiran, Moira Thomas, Adrian Thrasher, Steve Welch, Lisa Willcocks, Sarita Workman, Austen Worth, Nigel Yeatman, Patrick Yong, Sofie Ashford, John Bradley, Debra Fletcher, Tracey Hammerton, Roger James, Nathalie Kingston, Willem Ouwehand, Christopher Penkett, F Lucy Raymond, Kathleen Stirrups, Marijke Veltman, Tim Young, Sofie Ashford, Matthew Brown, Naomi Clements-Brod, John Davis, Eleanor Dewhurst, Marie Erwood, Amy Frary, Rachel Linger, Jennifer Martin, Sofia Papadia, Karola Rehnstrom, William Astle, Antony Attwood, Marta Bleda, Keren Carss, Louise Daugherty, Sri Deevi, Stefan Graf, Daniel Greene, Csaba Halmagyi, Matthias Haimel, Fengyuan Hu, Roger James, Hana Lango Allen, Vera Matser, Stuart Meacham, Karyn Megy, Christopher Penkett, Olga Shamardina, Kathleen Stirrups, Catherine Titterton, Salih Tuna, Ernest Turro, Ping Yu, Julie von Ziegenweldt, Abigail Furnell, Rutendo Mapeta, Ilenia Simeoni, Simon Staines, Jonathan Stephens, Kathleen Stirrups, Deborah Whitehorn, Paula Rayner-Matthews, and Christopher Watt. Loss-of-function nuclear factor κb subunit 1 (nfkb1) variants are the most common monogenic cause of common variable immunodeficiency in europeans. Journal of Allergy and Clinical Immunology, 142(4):1285–1296, October 2018. URL: http://dx.doi.org/10.1016/j.jaci.2018.01.039, doi:10.1016/j.jaci.2018.01.039. This article has 180 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2018.01.039)

[8. (Fliegauf2021A) Manfred Fliegauf, Renate Krüger, Sophie Steiner, Leif Gunnar Hanitsch, Sarah Büchel, Volker Wahn, Horst von Bernuth, and Bodo Grimbacher. A pathogenic missense variant in nfkb1 causes common variable immunodeficiency due to detrimental protein damage. Frontiers in Immunology, April 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.621503, doi:10.3389/fimmu.2021.621503. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.621503)

[9. (Moorthy2006The) Anu K Moorthy, Olga V Savinova, Jessica Q Ho, Vivien Ya-Fan Wang, Don Vu, and Gourisankar Ghosh. The 20s proteasome processes nf-κb1 p105 into p50 in a translation-independent manner. The EMBO Journal, 25(9):1945–1956, April 2006. URL: http://dx.doi.org/10.1038/sj.emboj.7601081, doi:10.1038/sj.emboj.7601081. This article has 197 citations.](https://doi.org/10.1038/sj.emboj.7601081)

[10. (Fliegauf2015Haploinsufficiency) Manfred Fliegauf, Vanessa L. Bryant, Natalie Frede, Charlotte Slade, See-Tarn Woon, Klaus Lehnert, Sandra Winzer, Alla Bulashevska, Thomas Scerri, Euphemia Leung, Anthony Jordan, Baerbel Keller, Esther de Vries, Hongzhi Cao, Fang Yang, Alejandro A. Schäffer, Klaus Warnatz, Peter Browett, Jo Douglass, Rohan V. Ameratunga, Jos W.M. van der Meer, and Bodo Grimbacher. Haploinsufficiency of the nf-κb1 subunit p50 in common variable immunodeficiency. The American Journal of Human Genetics, 97(3):389–403, September 2015. URL: http://dx.doi.org/10.1016/j.ajhg.2015.07.008, doi:10.1016/j.ajhg.2015.07.008. This article has 202 citations.](https://doi.org/10.1016/j.ajhg.2015.07.008)

[11. (Fliegauf2022Detrimental) Manfred Fliegauf, Matias Kinnunen, Sara Posadas-Cantera, Nadezhda Camacho-Ordonez, Hassan Abolhassani, Laia Alsina, Faranaz Atschekzei, Delfien J. Bogaert, Siobhan O. Burns, Joseph A. Church, Gregor Dückers, Alexandra F. Freeman, Lennart Hammarström, Leif Gunnar Hanitsch, Tessa Kerre, Robin Kobbe, Svetlana O. Sharapova, Kathrin Siepermann, Carsten Speckmann, Sophie Steiner, Nisha Verma, Jolan E. Walter, Emma Westermann-Clark, Sigune Goldacker, Klaus Warnatz, Markku Varjosalo, and Bodo Grimbacher. Detrimental nfkb1 missense variants affecting the rel-homology domain of p105/p50. Frontiers in Immunology, August 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.965326, doi:10.3389/fimmu.2022.965326. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.965326)